Literature DB >> 15471894

Reduced nucleotide excision repair and GSTM1-null genotypes influence anti-B[a]PDE-DNA adduct levels in mononuclear white blood cells of highly PAH-exposed coke oven workers.

Sofia Pavanello1, Alessandra Pulliero, Ewa Siwinska, Danuta Mielzynska, Erminio Clonfero.   

Abstract

It is important to identify the potential genetic-susceptible factors that are able to modulate individual responses to exposure to carcinogenic polycyclic aromatic hydrocarbons (PAHs). In the present study we evaluated the influence of four polymorphisms of nucleotide excision repair (NER) genes [xeroderma pigmentosum-C (XPC)-PAT +/-, xeroderma pigmentosum-A (XPA) 5' non-coding region-A23G, XPD-exon 23 A35931C Lys751Gln, xeroderma pigmentosum-D (XPD)-exon 10 G23591A Asp312Asn] and that of glutathione S-transferase mu1 (GSTM1-active or -null) on benzo[a]pyrene diol epoxide (B[a]PDE)-DNA adduct levels from the lympho-monocyte fraction (LMF) of highly PAH benzo[a]pyrene (B[a]P)-exposed Polish coke oven workers (n = 67, 67% current smokers) with individual urinary post-shift excretion of 1-pyrenol exceeding the proposed biological exposure index (BEI) (2.28 micromol/mol creatinine). The bulky (+/-)-r-7,t-8-dihydroxy-t-9,10-oxy-7,8,9,10-tetrahydrobenzo[a]pyrene (anti-B[a]PDE)-DNA adduct levels were detected by high-performance liquid chromatography (HPLC)/fluorescence analysis and genotypes by polymerase chain reaction. We found that workers with the low DNA repair capacity of XPC-PAT+/+ and XPA-A23A genotypes had significantly increased anti-B[a]PDE-DNA adduct levels (Mann-Whitney U-test, z = 2.24, P = 0.02 and z = 2.65, P = 0.01). Moreover, DNA adducts were also raised in workers without GSTM1 activity (GSTM1-null genotype) (Mann-Whitney U-test, z = 2.25, P = 0.0246). Workers with unfavourable XPC-PAT+/+ and XPA-A23A NER genotypes, alone (approximately 65% of workers) or combined with GSTM1-null genotype (approximately 75% of workers) were in the tertile with the highest adduct level, i.e. >4.11 adducts/10(8) nt (chi2 = 5.85, P = 0.0156 and chi2 = 5.40, P = 0.01). The increase in anti-B[a]PDE-DNA adduct levels (ln values) was significantly related in a multiple linear regression analysis to PAH exposure (i.e. urinary post-shift excretion of 1-pyrenol) (t = 2.61, P = 0.0115), lack of GSTM1 activity (t = 2.41, P = 0.0192) and to low DNA repair capacity of the XPC-PAT+/+ genotype (t = 2.34, P = 0.0226). The influence of the XPA-A23A genotype was not evident in this statistical analysis, and no associations with XPD polymorphisms, dietary habits or tobacco smoking were found. The modulation of anti-B[a]PDE-DNA adducts in the LMF by GSTM1-null and some low-activity NER genotypes may be considered as a potential genetic susceptibility factor capable of modulating individual responses to PAH (B[a]P) genotoxic exposure and the consequent risk of cancer in coke oven workers.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15471894     DOI: 10.1093/carcin/bgh303

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  20 in total

1.  Modulation of DNA damage/DNA repair capacity by XPC polymorphisms.

Authors:  Yimin Zhu; Hushan Yang; Qin Chen; Jie Lin; H Barton Grossman; Colin P Dinney; Xifeng Wu; Jian Gu
Journal:  DNA Repair (Amst)       Date:  2007-10-17

2.  Toxicokinetics of benzo[a]pyrene in humans: Extensive metabolism as determined by UPLC-accelerator mass spectrometry following oral micro-dosing.

Authors:  Erin Madeen; Lisbeth K Siddens; Sandra Uesugi; Tammie McQuistan; Richard A Corley; Jordan Smith; Katrina M Waters; Susan C Tilton; Kim A Anderson; Ted Ognibene; Kenneth Turteltaub; David E Williams
Journal:  Toxicol Appl Pharmacol       Date:  2018-12-21       Impact factor: 4.219

3.  XPD Lys751Gln polymorphism and esophageal cancer susceptibility: a meta-analysis of case-control studies.

Authors:  Da-Peng Ding; Wen-Li Ma; Xiao-Feng He; Ying Zhang
Journal:  Mol Biol Rep       Date:  2011-06-11       Impact factor: 2.316

4.  Association between the XPD/ERCC2 Lys751Gln polymorphism and risk of cancer: evidence from 224 case-control studies.

Authors:  Kai-Ge Wu; Xiao-Feng He; Yun-Hui Li; Wei-Bin Xie; Xi Huang
Journal:  Tumour Biol       Date:  2014-08-13

5.  XPD Lys(751)Gln and Asp (312)Asn polymorphisms and bladder cancer risk: a meta-analysis.

Authors:  Chunxiang Li; Zheng Jiang; Xinghan Liu
Journal:  Mol Biol Rep       Date:  2009-08-08       Impact factor: 2.316

6.  Polymorphisms of phase II xenobiotic-metabolizing and DNA repair genes and in vitro N-ethyl-N-nitrosourea-induced O6-ethylguanine levels in human lymphocytes.

Authors:  Li Jiao; Ping Chang; Pervez F Firozi; Dejian Lai; James L Abbruzzese; Donghui Li
Journal:  Mutat Res       Date:  2006-12-08       Impact factor: 2.433

7.  Benzo[a]pyrene (BaP) metabolites predominant in human plasma following escalating oral micro-dosing with [14C]-BaP.

Authors:  Monica L Vermillion Maier; Lisbeth K Siddens; Jamie M Pennington; Sandra L Uesugi; Kim A Anderson; Lane G Tidwell; Susan C Tilton; Ted J Ognibene; Kenneth W Turteltaub; Jordan N Smith; David E Williams
Journal:  Environ Int       Date:  2021-12-15       Impact factor: 9.621

8.  Shorter telomere length in peripheral blood lymphocytes of workers exposed to polycyclic aromatic hydrocarbons.

Authors:  Sofia Pavanello; Angela-C Pesatori; Laura Dioni; Mirjam Hoxha; Valentina Bollati; Ewa Siwinska; Danuta Mielzyńska; Claudia Bolognesi; Pier-Alberto Bertazzi; Andrea Baccarelli
Journal:  Carcinogenesis       Date:  2009-11-05       Impact factor: 4.944

9.  Patterns of persistent DNA damage associated with sun exposure and the glutathione S-transferase M1 genotype in melanoma patients.

Authors:  Mark L Steinberg; Karen Hubbard; Charles Utti; Brian Clas; Bor-Jang Hwang; Helene Z Hill; Irene Orlow
Journal:  Photochem Photobiol       Date:  2009 Jan-Feb       Impact factor: 3.421

10.  Xeroderma pigmentosum complementation group C genotypes/diplotypes play no independent or interaction role with polycyclic aromatic hydrocarbons-DNA adducts for breast cancer risk.

Authors:  Jing Shen; Marilie D Gammon; Mary Beth Terry; Susan L Teitelbaum; Sybil M Eng; Alfred I Neugut; Regina M Santella
Journal:  Eur J Cancer       Date:  2007-11-28       Impact factor: 9.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.